itacnosertib
- Generic Name
- itacnosertib
A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT04623996
- Locations
- 🇺🇸
BRCR Global, Plantation, Florida, United States
🇺🇸US Oncology - Austin Texas Oncology Midtown, Austin, Texas, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States
First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors
- First Posted Date
- 2018-02-12
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03429218
- Locations
- 🇺🇸
University of Texas Southwestern UTSW, Dallas, Texas, United States
🇺🇸Massachusetts General Hospital MGH, Boston, Massachusetts, United States
🇺🇸Northside Hospital, Atlanta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath